Thank you for your interest in the Vicore/Science 37 IPF Waiting Room.
This Waiting Room is being created in preparation for an upcoming Phase 3 clinical trial for idiopathic pulmonary fibrosis (IPF). By completing this short survey, you can join the Waiting Room and stay connected with our research team as information about the Phase 3 study becomes available.
Once you complete the survey, you will be added to the Waiting Room. Our team will periodically reach out by email and text message to stay in touch, provide updates, and let you know when there are opportunities to learn more about the upcoming study.
Joining the Waiting Room does not mean you are eligible for the study or guarantee that you will be invited to participate. When the study is ready to begin, we will provide more information about the study and, if appropriate, invite you to complete the screening process.
There is nothing else you need to do after completing this survey. We appreciate your interest in IPF research and look forward to staying connected with you.
- The Science 37 Research Team